LAS VEGAS—new research has uncovered several benefits associated with remote management of spinal cord stimulators, including a reduction in patient burdens and improvements in care. Interim results from the prospective, multicenter BENEFIT-03 study showed remote device management to be a highly useful tool, one that was well received by both patients and their clinicians. Read […]
A novel peptide for pain relief The researchers developed a novel peptide molecule that could prevent endocytosis to reduce the hyperactivity of these pain neurons and thereby minimise pain perception. “This novel peptide molecule is a lipidated endocytic dileucine sequence found in the human CD4 protein known to bind to the AP2 complex at the […]
Facebook Our country wasn’t the first to adopt PRP. Kobe Bryant had to run to Germany to get his first PRP treatment. And his success and his raving about his success contributed heavily to PRP’s skyrocketing popularity now. In fact, he’s the one who told Alex Rodriguez to get his PRP. Bryant is indeed the […]
Facebook Lumbar medial branch radiofrequency ablation (LRFA) and intraarticular facet steroid injections (FJI) are commonly performed for recalcitrant facet joint-mediated pain. However, no study has compared clinical outcomes of the two treatments in patients selected using dual medial branch blocks (MBBs) with an 80% relief threshold. Read the results at Oxford Academic. More to explorer
Facebook Cannabidiol (CBD), the major non-psychoactive constituent of Cannabis sativa L., has gained traction as a potential treatment for intractable chronic pain in many conditions. Clinical evidence suggests that CBD provides therapeutic benefit in certain forms of epilepsy and imparts analgesia in certain conditions, and improves quality of life. CBD continues to be Schedule I or […]
Facebook At three years post-Intracept Procedure, statistically significant (p<0.0001) improvements of 31.2 points and 4.3 points were observed compared to baseline, for mean Oswestry Disability Index (ODI) and mean numeric pain score (NPS), respectively. The study also found that 74% fewer patients were actively using opioid medications for low back pain and 84% fewer patients […]
Facebook Researchers from Harvard Medical School found non-ictal cephalic allodynia, established by a quick, inexpensive and noninvasive proprietary test, is an 86% accurate pretreatment predictor of anti-calcitonin gene–related peptide (CGRP) therapy response. To read the rest of the article head over to PainMedicineNews.com More to explorer
